Nina Devlin from New York, NY

Resumes

Senior Vice President, Chief Communications Officer

view source

Location:

New York, NY

Industry:

Biotechnology

Work:

Vertex Pharmaceuticals
Senior Vice President, Chief Communications Officer
Fda Oct 2017 - Feb 2019
Senior Communications Advisor
Mylan Jan 2011 - Oct 2017
Vice President, Head of Global Communications
Edelman May 2009 - Dec 2010
Senior Vice President, Corporate and Financial Communications
Brunswick Group Mar 2000 - Feb 2009
Partner

Education:

Georgetown University
Bachelors, Bachelor of Science, International Relations

Skills:

Crisis Communications
Public Relations
Investor Relations
Strategic Communications
Corporate Communications
Financial Communications
Strategy
Public Affairs
Reputation Management
Media Relations
Internal Communications
Message Development
Marketing
Marketing Communications
Social Media
Press Releases
Crisis Management
Brand Development
Integrated Marketing
Newsletters
Speech Writing
Communications Planning
Corporate Social Responsibility
Mergers and Acquisitions
Thought Leadership
Communication Training
Event Management
Spokesperson
Publicity
Reputation
International Relations
Global Communications
Messaging
Corporate Branding

Languages:

German

Nina Devlin

view source

Mylife

Nina E Devlin

view source

Tags:

Age: 36

Nina Devlin

view source

Tags:

Female, Age: 48

Locality:

Denver, CO

Myspace

Nina Devlin

view source

Locality:

United Kingdom

Gender:

Female

Birthday:

1944

Nina Devlin

view source

Locality:

Fishoek, Cape Town

Gender:

Female

Birthday:

1948

Facebook

Nina Devlin

view source

Nina Devlin

view source

News

Waiting for cheaper EpiPen? It may not come…

view source

The authorized generic version of EpiPen will be available by the end of the year, Mylan spokeswoman Nina Devlin said in an e-mail Monday. Five weeks ago, in a statement on Aug. 29, the company had said it expected to introduce the generic version in several weeks. Mylans generic version will
Date: Oct 04, 2016
Category: Business
Source: Google

Congress Seeks More Information On Mylan's EpiPen Profits

view source

In response to the letter, Mylan spokesman Nina Devlin reportedly said the company remains committed to productive and continued cooperation with the committee, and that it intends to respond to the request for additional information.
Date: Oct 04, 2016
Category: Business
Source: Google

Cheaper EpiPen May Not Come Until End of Year, Mylan Says

view source

The cheaper version of the shot -- an authorized generic that Mylan has said will cost $300 for a two pack -- will be available by the end of the year, Mylan spokeswoman Nina Devlin said in an e-mail Monday. Five weeks ago, in a statement on Aug. 29, the company had said it expected to introduce
Date: Oct 03, 2016
Category: Business
Source: Google

Mylan's EpiPen profits are 60 percent more than it told Congress, report says

view source

Tax is typically included in a standard profitability analysis, and the information provided to Congress has made clear that tax was part of the EpiPen Auto-Injector profitability analysis, Mylan spokeswoman Nina Devlin said in a statement. It also is important to note that use of a statutory
Date: Sep 26, 2016
Category: Business
Source: Google

Blame Game: $130 Billion Fees That Drugmakers Say Push Up Prices

view source

overnment Reform Wednesday, said she regrets that some patients had difficulty affording EpiPen. She also pointed to the opaque and frustrating pricing system for drugs, which contributing to a misconception about the actual price of EpiPen. Nina Devlin, a company spokeswoman, declined to comment.
Date: Sep 21, 2016
Category: Business
Source: Google

Senate Republicans Seek Probe of Mylan's EpiPen Oversight

view source

West Virginia Attorney General Patrick Morrisey said he was investigating the rebates and the possibility that Mylan violated the state's antitrust law when it sued and settled with a would-be generic competitor. Mylan spokeswoman Nina Devlin said the company was cooperating with the investigation.
Date: Sep 20, 2016
Category: Business
Source: Google

Here's why drug prices rise even when there's plenty of competition

view source

Nina Devlin, a Mylan spokeswoman, said ursodiols price increase happened while the company was out of the market. She said Mylan reintroduced the drug in January at what had become the current market price.
Date: Sep 01, 2016
Category: Business
Source: Google

Think EpiPen is Mylan's first scandal? Here's a timeline of jet use, an unearned MBA and more

view source

Perfectly fine, said Mylan at the time. "Mr. Coury's family members have occasionally been passengers on the corporate aircraft," spokeswoman Nina Devlin told the WSJ back then. The value of Courys personal aircraft use in 2011? $500,000. The company had stopped covering Courys tax bill for the pe
Date: Aug 30, 2016
Category: Business
Source: Google